Showing results (651-660 of 10,763) with videos related to

Sort By:
Pageof 1,077
Diabetologia|October 1, 2021
The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traitsInês Barroso
Diabetologia|September 23, 2021
IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetesMontgomery Blencowe, Allison Furterer, Qing Wang, et al.
Diabetologia|October 27, 2021
A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER studySimon R Heller, Milan S Geybels, Ahmed Iqbal, et al.
Diabetologia|October 31, 2021
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studiesSabrina Schlesinger, Manuela Neuenschwander, Janett Barbaresko, et al.
Diabetologia|May 2, 2022
Genetic risk of type 2 diabetes modifies the effects of a lifestyle intervention aimed at the prevention of gestational and postpartum diabetesEmilia Huvinen, Jari Lahti, Miira M Klemetti, et al.
Diabetologia|May 5, 2022
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockadeEmi Kawada-Horitani, Shunbun Kita, Tomonori Okita, et al.
Diabetologia|July 22, 2022
Assessment of the bi-directional relationship between blood mitochondrial DNA copy number and type 2 diabetes mellitus: a multivariable-adjusted regression and Mendelian randomisation studyWenyi Wang, Jiao Luo, Ko Willems van Dijk, et al.
Diabetologia|November 1, 1986
Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetesL Groop, P H Groop, S Koskimies
Diabetologia|April 21, 2022
Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemiaSvenja Meyhöfer, Katharina Dembinski, Bernd Schultes, et al.
Diabetologia|April 21, 2022
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trialSimke W Waijer, Priya Vart, David Z I Cherney, et al.
Pageof 1,077